Clinical trial
Lopinavir Capsules to Kaletra or Invirase Tablets
NCT00438152 · Royal Free Hampstead NHS Trust, Other · Completed
Key facts
| NCT number | NCT00438152 |
|---|---|
| Title | Lopinavir Capsules to Kaletra or Invirase Tablets |
| Official title | A 24-week, Randomized, Open-label, 2-arm Study to Compare the Safety, Efficacy and Tolerability of Invirase® Tablets With Ritonavir Versus Kaletra® Tablets in HIV 1 Infected Adults on a Kaletra® Based Regimen With 2 Nucleosides/Nucleotides |
| Acronym | LoCKIT |
| Lead sponsor | Royal Free Hampstead NHS Trust, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Saquinavir (Invirase®), Lopinavir/ritonavir (Kaletra®) |
| Enrollment | 53 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 21, 2007 |
| Last update posted | Jul 18, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: